Loading clinical trials...

COMPLETEDNA

Acupuncture as Treatment of Post-herpetic Neuralgia: A RCT A Double-blinded Randomized Clinical Trial.

Acupuncture (Dry-needling) as Treatment of Post-herpetic Neuralgia: A Double-blinded Randomized Clinical Trial.

NCT03974438•Odense University Hospital

Summary

The aim of this study is to perform the first RCT investigating the possible effect of superficial dry-needling (SDN) - a special kind of acupuncture used for PHN. The participants will be divided into two groups. Group A, the intervention group will receive SDN in the area of pain. Group B, the control group will receive a sham procedure.

Detailed Description

The aim of this study is to investigate the possible effect of SDN on PHN. The study population consists of patients with chronic pain after herpes zoster. The study is a controlled double-blinded randomized study. The participants will be divided into two groups, group A, the intervention group, will receive SDN in the area of pain. Group B, the control group will receive a sham procedure. The procedure will take place at the out-patient clinic at Odense University Hospital. The plan is to include 40 patients (20 in each group).

Eligibility

Age

55 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Age between 50-75 years.
•Pain in the dermatomal area of the previous outbreak of HZ.
•Pain located to a dermatome originating from the thoracic or lumbar spine.
•At least six months since the outbreak.
•Understands the purpose of the study and is able to give consent.

Exclusion Criteria

•A psychiatric illness affecting participation in the study.
•Active cancer
•Pregnancy

Locations (1)

Odense University Hospital

Odense, Funen, Denmark

Key Dates

Start Date

September 19, 2019

Primary Completion Date

September 14, 2020

Completion Date

September 14, 2020

Last Updated

September 16, 2020

Enrollment

ACTUAL participants

Conditions

Post Herpetic Neuralgia

Interventions

Superficial dry needling / Acupunture

PROCEDURE

Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain

NCT04144972

Spinal Cord InjuriesNerve Injury+7 more

View study

RECRUITINGPHASE1

A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.

NCT06218784

Post Herpetic NeuralgiaPain+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 16, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Acupuncture as Treatment of Post-herpetic Neuralgia: A RCT A Double-blinded Randomized Clinical Trial.

Inclusion Criteria

Exclusion Criteria

Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain

A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.

Predictive Models for the Treatment of Recurrent Herpes Zoster Neuralgia Following Spinal Cord Electrical Stimulation.

Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia

Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia